Lobe Sciences Ltd. (CSE:LOBE)

Canada flag Canada · Delayed Price · Currency is CAD
0.0400
0.00 (0.00%)
Jul 17, 2025, 11:10 AM EDT
100.00%
Market Cap7.73M
Revenue (ttm)n/a
Net Income (ttm)-4.76M
Shares Out193.20M
EPS (ttm)-0.03
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume20,000
Average Volume15,477
Open0.0400
Previous Close0.0400
Day's Range0.0400 - 0.0400
52-Week Range0.0100 - 0.0400
Beta2.02
RSI62.31
Earnings DateJul 24, 2025

About Lobe Sciences

Lobe Sciences Ltd., a biopharmaceutical company, engages in the research and development using sub-hallucinatory doses of proprietary psychedelic compounds to improve brain and mental health, and wellness in Canada. The company was formerly known as Greenstar Biosciences Corp. and changed its name to Lobe Sciences Ltd. in November 2020. Lobe Sciences Ltd. was founded in 2018 and is headquartered in Vancouver, Canada. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2018
Country Canada
Stock Exchange Canadian Securities Exchange
Ticker Symbol LOBE
Full Company Profile

Financial Performance

In 2024, Lobe Sciences's revenue was 136,205, a decrease of -83.80% compared to the previous year's 840,534. Losses were -4.42 million, -6.09% less than in 2023.

Financial Statements

News

There is no news available yet.